Sanofi Genzyme
About Sanofi Genzyme
Sanofi Genzyme provides biotechnology products including therapeutics for rare disorders, renal diseases, orthopedics, cancer, transplant and immune disease, and diagnostic and predictive testing. It is based in Paris, France.
Sanofi Genzyme Headquarter Location
54, rue La Boetie
Paris, 75008,
France
Expert Collections containing Sanofi Genzyme
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Sanofi Genzyme is included in 2 Expert Collections, including Health Monitoring & Diagnostics.
Health Monitoring & Diagnostics
2,394 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Medical Devices
295 items
Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA
Latest Sanofi Genzyme News
Feb 9, 2022
"Glucosylceramide Synthase Inhibitor - Pipeline Insight, 2022" report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Glucosylceramide Synthase Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Descriptive coverage of pipeline development activities for Glucosylceramide Synthase Inhibitor Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for Glucosylceramide Synthase Inhibitor The report assesses the active Glucosylceramide Synthase Inhibitor pipeline products by developmental stage, product type, molecule type, and administration route. Scope of the Report Provides a snapshot of the therapeutics pipeline activity for Glucosylceramide Synthase Inhibitor Features the Glucosylceramide Synthase Inhibitor pipeline across the complete product development cycle including all clinical and non-clinical stages Offers detailed therapeutic product profiles of Glucosylceramide Synthase Inhibitor with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration Coverage of dormant and discontinued pipeline projects across Glucosylceramide Synthase Inhibitor Key Topics Covered:
Sanofi Genzyme Web Traffic
Sanofi Genzyme Rank
Where is Sanofi Genzyme's headquarters?
Sanofi Genzyme's headquarters is located at 54, rue La Boetie, Paris.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.